Try our mobile app

Switch to company model in classical logic    *

General information

Country: NETHERLANDS

Sector: Biotechnology

Merus NV is a clinical-stage immune-oncology company, which engages in the discovery and development of bi-specific antibody therapeutics. The company is headquartered in Utrecht, Utrecht and currently employs 98 full-time employees. The firm develops differentiating therapeutics for cancer patients. The product programs in the Merus pipeline are based on the Biclonics format. Its products include, among others, MCLA-134 that is designed to bind to a combination of two immunomodulatory targets expressed by T cells, as well as MCLA-145 that is designed to bind to a tumor-associated target with an immunomodulatory target involved in checkpoint inhibition.
Website: merus.nl



Growth: Bad revenue growth rate 0.0%, there is acceleration compared to average historical growth rates -4.5%. The revenue growth dynamics is unstable

Profitability: LTM EBITDA margin is negative, -750.0%. On average the margin is decreasing steadily. Gross margin is normal, +37.2%. In the last quarter the company beat the estimated EPS. The company was ahead of estimated EPS in 80% of quarters (showing a gain of -$0.01 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield 3.0% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 461.8% higher than minimum and 7.2% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued -35.4x by EV / Sales multiple

Insiders: For the last 3 months insiders sold company shares on $7 125.2 mln (-107.621% of cap.)

Key Financials (Download financials)

Ticker: MRUS
Share price, USD:  (0.0%)90
year average price 67.98  


year start price 41.25 2025-02-08

min close price 34.89 2025-04-08

max close price 97.01 2025-12-19

current price 90.00 2026-02-07
Common stocks: 68 254 120

Dividend Yield:  0.0%
EV / Sales: 155.8x
Margin (EBITDA LTM / Revenue): -750.0%
Fundamental value created in LTM:
Market Cap ($m): 6 143
Net Debt ($m): -535
EV (Enterprise Value): 5 608
Price to Book: 9.3x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2025-10-01globenewswire.com

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EA and MRUS on Behalf of Shareholders

2025-09-30prnewswire.com

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of 1st Merus N.V. (NASDAQ: MRUS)

2025-09-29marketwatch.com

Months after cancer drug trial, Merus agrees to be bought at 41% premium

2025-08-05zacks.com

Merus N.V. (MRUS) Reports Q2 Loss, Misses Revenue Estimates

2025-07-11zacks.com

MRUS Stock Soars 30% in 3 Months After Phase II Cancer Study Success

2025-06-05youtube.com

Merus CEO: We're really optimistic about the potential for our drug in head and neck cancer

2025-06-04globenewswire.com

Merus N.V. Announces Pricing of Public Offering of Common Shares

2025-05-22globenewswire.com

Merus' Petosemtamab with Pembrolizumab Interim Data Demonstrates Robust Efficacy and Durability in 1L PD-L1+ r/m HNSCC

2025-05-07zacks.com

Merus N.V. (MRUS) Reports Q1 Loss, Tops Revenue Estimates

2025-04-07seekingalpha.com

Merus: Riding The Bispecific Wave In Oncology
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q2 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2021-12-31 2020-12-31
symbol MRUS MRUS MRUS MRUS MRUS MRUS MRUS MRUS MRUS MRUS MRUS MRUS MRUS MRUS MRUS
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2025-10-31 2025-08-05 2024-10-31 2024-08-01 2024-05-08 2023-11-02 2023-08-07 2023-05-04 2022-11-03 2022-08-08
acceptedDate 2025-10-31 16:00:52 2025-08-05 16:01:03 2025-02-27 16:05:39 2024-10-31 08:00:21 2024-08-01 16:05:29 2024-05-08 16:05:47 2024-02-28 16:05:45 2023-11-02 16:05:34 2023-08-07 16:13:03 2023-05-04 16:06:16 2023-02-28 16:09:13 2022-11-03 07:31:22 2022-08-08 16:08:00 2022-02-28 16:15:48 2021-03-16 16:22:13
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 Q2 FY FY
revenue 10M 7M 35M 12M 7M 8M 40M 11M 10M 13M 39M 7M 13M 43M 25M
costOfRevenue 548 986 80M 22M 0 0 607 000 11M 35M 26M 0 10M 0 0 86M 57M
grossProfit 10M -72M 13M 12M 7M 7M 29M -24M -15M 13M 29M 7M 0 -43M -33M
grossProfitRatio 0.947 -9.64 1 1 0.923 -2.156 -1.475 1 1 0
researchAndDevelopmentExpenses 68M 80M 230M 63M 49M 39M 133M 37M 28M 35M 148M 42M 31M 94M 62M
generalAndAdministrativeExpenses 24M 21M 80M 21M 23M 16M 54M 13M 16M 15M 49M 12M 13M 36M 29M
sellingAndMarketingExpenses 0 0 0 0 -640 000 -607 000 0 0 0 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 24M 21M 80M 21M 22M 16M 54M 13M 16M 15M 49M 12M 13M 36M 29M
otherExpenses 0 -80M -34M 0 0 0 -16M 0 0 0 -19M 0 0 -94M -62M
operatingExpenses 92M 21M 276M 84M 71M 54M 171M 49M 44M 50M 178M 55M 44M 36M 29M
costAndExpenses 93M 101M 298M 84M 72M 55M 182M 49M 44M 50M 188M 55M 44M 122M 87M
interestIncome 8M 7M 31M 10M 7M 0 15M 5M 3M 0 3M 0 0 0 300 000
interestExpense 0 0 0 0 0 0 0 0 0 2M 0 866 000 316 000 129 000 0
depreciationAndAmortization 548 986 539 115 2M 635 000 640 000 607 000 2M 659 000 675 000 6M 1M -23M 322 000 1M 1M
ebitda -76M -93M -260M -96M -59M -46M -139M -22M -34M -31M -148M -71M -5M -78M -61M
ebitdaratio -7.33 -12.428 -8.18 -8.693 -5.857 -1.984 -3.223 -2.276 -10.779 -0.39
operatingIncome -82M -94M -263M -72M -64M -47M -142M -22M -34M -37M -149M -48M -31M -79M -62M
operatingIncomeRatio -7.941 -12.5 -6.136 -8.78 -5.933 -1.984 -3.235 -2.723 -7.323 -2.452
totalOtherIncomeExpensesNet 6M -39M 63M -25M 12M 13M 4M 12M 551 000 -3M 28M 24M 26M 21M -7M
incomeBeforeTax -77M -133M -200M -97M -48M -33M -137M -22M -31M -40M -122M -24M -6M -58M -70M
incomeBeforeTaxRatio -7.383 -17.71 -8.234 -6.509 -4.228 -1.984 -2.915 -2.978 -3.691 -0.44
incomeTaxExpense 5M 2M 8M 3M 2M 1M 3M 1M 1M -457 000 895 610 327 000 131 000 209 985 411 755
netIncome -82M -134M -208M -100M -50M -34M -140M -23M -32M -40M -123M -25M -6M -59M -70M
netIncomeRatio -7.862 -17.922 -8.487 -6.825 -4.368 -2.086 -3.058 -2.944 -3.74 -0.45
eps -1.26 -2.23 -3.35 -1.46 -0.81 -0.59 -3 -0.43 -0.66 -0.86 -2.92 -0.53 -0.13 -1.73 -2.92
epsdiluted -1.26 -2.23 -1.46 -0.81 -0.59 -0.43 -0.66 -0.86 -0.53 -0.13
weightedAverageShsOut 76M 71M 64M 68M 62M 58M 52M 54M 48M 46M 45M 46M 44M 39M 29M
weightedAverageShsOutDil 76M 71M 64M 68M 62M 58M 52M 54M 48M 46M 45M 46M 44M 39M 29M
link Link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link Link
filingDate 2025-02-27 2024-02-28 2023-02-28 2022-02-28 2021-03-16
fiscalYear 2024 2023 2022 2021 2020
netInterestIncome 31M 15M 3M -129 000 300 000
ebit -263M -142M -149M -79M -62M
nonOperatingIncomeExcludingInterest 0 0 0 0 0
netIncomeFromContinuingOperations -208M -140M -123M -59M -70M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome -208M -140M -123M -59M -70M
epsDiluted -3.35 -3 -2.92 -1.73 -2.92

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q2 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2021-12-31 2020-12-31
symbol MRUS MRUS MRUS MRUS MRUS MRUS MRUS MRUS MRUS MRUS MRUS MRUS MRUS MRUS MRUS
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2025-10-31 2025-08-05 2024-10-31 2024-08-01 2024-05-08 2023-11-02 2023-08-07 2023-05-04 2022-11-03 2022-08-08
acceptedDate 2025-10-31 16:00:52 2025-08-05 16:01:03 2025-02-27 16:05:39 2024-10-31 08:00:21 2024-08-01 16:05:29 2024-05-08 16:05:47 2024-02-28 16:05:45 2023-11-02 16:05:34 2023-08-07 16:13:03 2023-05-04 16:06:16 2023-02-28 16:09:13 2022-11-03 07:31:22 2022-08-08 16:08:00 2022-02-28 16:15:48 2021-03-16 16:22:13
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 Q2 FY FY
cashAndCashEquivalents 314M 443M 293M 433M 629M 178M 205M 242M 101M 103M 148M 191M 214M 241M 163M
shortTermInvestments 229M 267M 244M 199M 158M 159M 150M 147M 164M 139M 142M 160M 162M 169M 45M
cashAndShortTermInvestments 543M 710M 537M 632M 787M 337M 355M 389M 265M 241M 290M 351M 376M 410M 208M
netReceivables 19M 21M 5M 4M 4M 60M 4M 5M 4M 6M 5M 3M 4M 7M 2M
inventory 0 0 0 0 0 1 0 10M 12M 9M 0 0 0 0 0
otherCurrentAssets 28M 37M 2M 30M 15M 12M 727 000 1M 2M 2M 2M 951 000 18M 2M 1M
totalCurrentAssets 591M 768M 569M 666M 807M 410M 369M 405M 283M 258M 306M 368M 399M 424M 218M
propertyPlantEquipmentNet 20M 22M 20M 22M 22M 22M 23M 23M 25M 26M 25M 20M 20M 7M 8M
goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
intangibleAssets 1M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 0 2M 3M
goodwillAndIntangibleAssets 1M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 3M
longTermInvestments 156M 184M 187M 151M 59M 61M 57M 57M 47M 46M 36M 21M 21M 20M 0
taxAssets 1M 758 000 4M 838 000 543 000 277 000 1M 702 000 3M 2M 2M 435 000 241 000 417 000 410 000
otherNonCurrentAssets 3M 4M 953 000 3M 2M 3M 3M 4M 4M 4M 5M 3M 3M 2M 2M
totalNonCurrentAssets 181M 212M 214M 178M 86M 88M 87M 87M 80M 80M 70M 47M 46M 32M 13M
otherAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalAssets 772M 980M 785M 845M 892M 498M 455M 492M 364M 339M 377M 415M 445M 457M 231M
accountPayables 7M 21M 4M 6M 4M 7M 5M 4M 8M 5M 10M 3M 7M 13M 3M
shortTermDebt 2M 2M 2M 4M 3M 2M 0 2M 2M 2M 0 2M 1M 0 0
taxPayables 7M 478 000 7M 5M 2M 2M 2M 137 000 1M 2M 2M 0 0 0 206 000
deferredRevenue 21M 26M 30M 31M 32M 34M 23M 23M 24M 27M 29M 28M 31M 35M 20M
otherCurrentLiabilities 37M 41M 103 000 35M 39M 35M 35 000 36M 32M 42M 38 000 31M 21M 1M 11 000
totalCurrentLiabilities 74M 92M 87M 80M 81M 78M 69M 64M 66M 75M 79M 64M 60M 72M 47M
longTermDebt 8M 9M 0 9M 9M 10M 0 11M 11M 12M 0 11M 12M 0 0
deferredRevenueNonCurrent 28M 38M 39M 52M 55M 60M 20M 24M 29M 34M 39M 41M 46M 66M 80M
deferredTaxLiabilitiesNonCurrent 0 0 0 0 -9M -10M 0 -11M -11M -12M 0 0 0 0 1M
otherNonCurrentLiabilities 0 0 0 0 0 10M 0 11M 11M 12M 0 19M 0 0 -1M
totalNonCurrentLiabilities 36M 47M 48M 61M 65M 70M 30M 34M 40M 46M 51M 52M 58M 69M 82M
otherLiabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 8M 11M 8M 11M 11M 10M 12M 12M 13M 13M 13M 13M 14M 4M 4M
totalLiabilities 110M 138M 135M 141M 145M 149M 99M 99M 106M 121M 129M 116M 118M 140M 129M
preferredStock 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
commonStock 7M 8M 7M 7M 7M 6M 6M 6M 5M 5M 5M 5M 5M 4M 3M
retainedEarnings -1 126M -1 223M -968M -937M -838M -788M -753M -693M -670M -638M -598M -516M -492M -467M -400M
accumulatedOtherComprehensiveIncomeLoss 17M 18M -55M -7M -39M -30M -23M -37M -27M -26M -30M -55M -35M -9M 9M
othertotalStockholdersEquity 1 764M 2 039M 1 641M 1 616M 1 161M 1 118M 949M 877M 865M 849M
totalStockholdersEquity 662M 842M 648M 703M 747M 349M 356M 393M 257M 218M 247M 299M 327M 316M 102M
totalEquity 662M 842M 648M 703M 747M 349M 356M 393M 257M 218M 247M 299M 327M 316M 102M
totalLiabilitiesAndStockholdersEquity 772M 980M 845M 892M 498M 492M 364M 339M 415M 445M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 772M 980M 783M 845M 892M 498M 455M 492M 364M 339M 377M 415M 445M 457M 231M
totalInvestments 385M 452M 431M 350M 217M 220M 207M 147M 164M 139M 179M 182M 183M 189M 45M
totalDebt 11M 11M 10M 2M 11M 12M 12M 12M 13M 13M 13M 13M 14M 4M 4M
netDebt -303M -432M -283M -431M -618M -167M -193M -230M -88M -89M -134M -178M -200M -238M -159M
link Link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link Link
filingDate 2025-02-27 2024-02-28 2023-02-28 2022-02-28 2021-03-16
fiscalYear 2024 2023 2022 2021 2020
accountsReceivables 1M 2M 4M 6M 2M
otherReceivables 3M 2M 647 000 367 000 80 000
prepaids 26M 9M 9M 5M 7M
totalPayables 11M 6M 12M 13M 3M
otherPayables 7M 2M 2M 0 206 000
accruedExpenses 44M 38M 36M 21M 22M
capitalLeaseObligationsCurrent 0 2M 2M 1M 1M
capitalLeaseObligationsNonCurrent 8M 10M 12M 2M 3M
treasuryStock 0 0 0 0 0
additionalPaidInCapital 1 665M 1 126M 871M 788M 490M
otherTotalStockholdersEquity 0 0 0 0 0

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q2 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2021-12-31 2020-12-31
symbol MRUS MRUS MRUS MRUS MRUS MRUS MRUS MRUS MRUS MRUS MRUS MRUS MRUS MRUS MRUS
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2025-10-31 2025-08-05 2024-10-31 2024-08-01 2024-05-08 2023-11-02 2023-08-07 2023-05-04 2022-11-03 2022-08-08
acceptedDate 2025-10-31 16:00:52 2025-08-05 16:01:03 2025-02-27 16:05:39 2024-10-31 08:00:21 2024-08-01 16:05:29 2024-05-08 16:05:47 2024-02-28 16:05:45 2023-11-02 16:05:34 2023-08-07 16:13:03 2023-05-04 16:06:16 2023-02-28 16:09:13 2022-11-03 07:31:22 2022-08-08 16:08:00 2022-02-28 16:15:48 2021-03-16 16:22:13
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 Q2 FY FY
netIncome -96M -158M -215M -100M -50M -34M -155M -23M -32M -40M -131M -25M -6M -67M -86M
depreciationAndAmortization 643 000 635 000 2M 635 000 640 000 607 000 3M 659 000 675 000 588 000 1M 300 000 322 000 1M 1M
deferredIncomeTax -390 807 -395 000 -321 000 -287 581 -268 625 923 000 842 000 2M -687 000 -328 000 -2M -195 000 -161 000 -7000 -122 000
stockBasedCompensation 21M 20M 46M 13M 12M 5M 26M 7M 6M 6M 25M 7M 7M 17M 9M
changeInWorkingCapital -7M 1M 24M -23M 52M -6M -26M -3M -15M -8M -19M -4M 9M 16M -14M
accountsReceivables -2M -2M 1M 792 572 57M -57M 2M -681 000 2M -631 000 2M 1M -2M -5M 1M
inventory 0 0 0 0 0 0 0 6M -12M 0 0 0 0 0 4M
accountsPayables -10M 10M -136 000 2M -3M 3M -4M -4M 3M -3M -4M -3M 2M 11M -110 000
otherWorkingCapital 5M -7M 23M -25M -2M 47M -24M -5M -8M -4M -17M -2M -9M 10M -19M
otherNonCashItems -3M 67M -43M 29M -49M 50M 9M -11M -833 000 5M -24M -19M 0 -27M 9M
netCashProvidedByOperatingActivities -85M -69M -186M -80M 6M -44M -142M -28M -42M -37M -150M -41M -32M -60M -80M
investmentsInPropertyPlantAndEquipment -328 000 -88 000 -2M -114 152 -1M -63 000 -4M -39 000 -349 000 -4M -8M -2M -3M -870 000 -1M
acquisitionsNet 0 0 0 0 0 0 52 000 -8M 22M 0 52 000 0 0 0 162 901
purchasesOfInvestments 0 -86M -410M -197M -40M -59M -235M -60M -79M -65M -220M -51M -65M -216M -67M
salesMaturitiesOfInvestments 0 79M 192M 63M 45M 47M 212M 68M 55M 60M 230M 52M 72M 70M 67M
otherInvestingActivites 657 000 0 -162 999 0 -11M 8M -22M 0 0 0
netCashUsedForInvestingActivites 329 000 -7M -134M 3M -12M 8M -25M -8M -1M 4M
debtRepayment 0 0 0 0 0 0 0 0 0 0
commonStockIssued 0 346M -38M 435M 30M 162M 67M 0 10M 48M
commonStockRepurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
dividendsPaid 0 0 0 0 0 0 0 0 0 0
otherFinancingActivites 6M -13M 11M 10M 30M 253 000 -552 478 217 000 150 000 184 000
netCashUsedProvidedByFinancingActivities 6M 333M 11M 443M 30M 162M 66M 217 000 10M 48M
effectOfForexChangesOnCash 3M -11M 1M 7M -2M 222 000 -4M -2M -1M -171 000 -5M 10M -799 000 3M 7M
netChangeInCash -75M 246M 89M -196M 451M -27M 57M 141M -1M -45M -93M -22M 20M 78M -35M
cashAtEndOfPeriod 368M 444M 294M 434M 629M 178M 205M 243M 102M 103M 148M 192M 215M 242M 163M
cashAtBeginningOfPeriod 444M 198M 205M 629M 178M 205M 148M 102M 103M 148M 242M 215M 195M 163M 198M
operatingCashFlow -85M -69M -186M -81M 6M -44M -142M -28M -42M -37M -150M -41M -32M -60M -80M
capitalExpenditure -328 000 -88 000 -2M -114 152 -1M -63 000 -4M -39 000 -349 000 -4M -8M -2M -3M -870 000 -1M
freeCashFlow -85M -69M -188M -81M 4M -44M -146M -28M -42M -40M -158M -44M -35M -60M -81M
link Link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link Link
filingDate 2025-02-27 2024-02-28 2023-02-28 2022-02-28 2021-03-16
fiscalYear 2024 2023 2022 2021 2020
otherInvestingActivities -163 000 -52 000 -52 000 0 -162 901
netCashProvidedByInvestingActivities -220M -27M 3M -147M -1M
netDebtIssuance 0 0 0 0 0
longTermNetDebtIssuance 0 0 0 0 0
shortTermNetDebtIssuance 0 0 0 0 0
netStockIssuance 457M 226M 58M 265M 38M
netCommonStockIssuance 457M 226M 58M 265M 38M
commonStockIssuance 457M 226M 58M 265M 38M
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid 0 0 0 0 0
commonDividendsPaid 0 0 0 0 0
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities 37M 4M 999 000 17M 1M
netCashProvidedByFinancingActivities 494M 230M 59M 282M 40M
incomeTaxesPaid 3M 3M 0 635 000 322 000
interestPaid 0 0 0 0 0

Earning call transcript

SEC forms

Show financial reports only

SEC form 10
2025-10-31 20:00 ET
Merus reported for 2025 q3
SEC form 8
2025-09-29 12:30 ET
Merus published news for 2025 q2
SEC form 8
2025-09-29 12:30 ET
Merus published news for 2025 q2
SEC form 8
2025-09-29 12:30 ET
Merus published news for 2025 q2
SEC form 8
2025-09-29 12:30 ET
Merus published news for 2025 q2
SEC form 10
2025-08-05 20:01 ET
Merus reported for 2025 q2
SEC form 8
2025-06-04 21:36 ET
Merus published news for 2025 q1
SEC form 8
2025-06-04 21:36 ET
Merus published news for 2025 q1
SEC form 8
2025-06-04 21:36 ET
Merus published news for 2025 q1
SEC form 10
2025-05-07 20:05 ET
Merus reported for 2025 q1
SEC form 10
2025-05-07 00:00 ET
Merus reported for 2025 q1
SEC form 10
2025-05-07 00:00 ET
Merus published news for 2013 q4
SEC form 10
2025-02-27 21:05 ET
Merus published news for 2024 q4
SEC form 10
2025-02-27 00:00 ET
Merus published news for 2013 q4
SEC form 10
2025-02-27 00:00 ET
Merus reported for 2024 q4
SEC form 10
2024-10-31 08:00 ET
Merus reported for 2024 q3
SEC form 10
2024-08-01 16:05 ET
Merus published news for 2024 q2
SEC form 10
2024-08-01 00:00 ET
Merus reported for 2024 q2
SEC form 10
2024-05-08 00:00 ET
Merus reported for 2024 q1
SEC form 10
2024-02-28 16:05 ET
Merus reported for 2023 q4
SEC form 10
2024-02-28 00:00 ET
Merus published news for 2023 q4
SEC form 10
2023-11-02 16:05 ET
Merus reported for 2023 q3
SEC form 10
2023-11-02 00:00 ET
Merus published news for 2023 q3
SEC form 10
2023-08-07 16:13 ET
Merus reported for 2023 q2
SEC form 10
2023-08-07 00:00 ET
Merus published news for 2023 q2
SEC form 6
2023-06-15 07:30 ET
Merus published news for 2023 q1
SEC form 10
2023-05-04 00:00 ET
Merus reported for 2023 q1
SEC form 10
2023-02-28 16:09 ET
Merus reported for 2022 q4
SEC form 10
2023-02-28 00:00 ET
Merus published news for 2022 q4
SEC form 6
2023-01-09 06:10 ET
Merus published news for 2022 q4
SEC form 6
2023-01-06 08:00 ET
Merus published news for 2022 q4
SEC form 10
2022-11-03 07:31 ET
Merus reported for 2022 q3
SEC form 10
2022-11-03 00:00 ET
Merus reported for 2022 q3
SEC form 10
2022-08-08 16:08 ET
Merus reported for 2022 q2
SEC form 10
2022-08-08 00:00 ET
Merus reported for 2022 q2
SEC form 6
2022-05-31 17:14 ET
Merus published news for 2022 q1
SEC form 10
2022-05-09 16:06 ET
Merus reported for 2022 q1
SEC form 10
2022-05-09 00:00 ET
Merus reported for 2022 q1
SEC form 6
2022-04-29 08:15 ET
Merus published news for 2022 q1
SEC form 6
2022-04-19 06:05 ET
Merus published news for 2022 q1
SEC form 10
2022-02-28 16:15 ET
Merus published news for 2021 q4
SEC form 10
2022-02-28 00:00 ET
Merus published news for 2021 q4
SEC form 6
2022-01-25 16:42 ET
Merus published news for 2021 q4
SEC form 6
2021-11-08 17:25 ET
Merus published news for 2021 q3
SEC form 10
2021-11-02 16:06 ET
Merus published news for 2021 q3
SEC form 10
2021-11-02 00:00 ET
Merus published news for 2021 q3
SEC form 10
2021-08-05 16:09 ET
Merus published news for 2021 q2
SEC form 10
2021-08-05 00:00 ET
Merus published news for 2021 q2
SEC form 6
2021-06-02 16:05 ET
Merus published news for 2021 q1
SEC form 6
2021-05-28 17:27 ET
Merus published news for 2021 q1
SEC form 6
2021-05-06 19:00 ET
Merus published news for 2021 q1
SEC form 10
2021-05-06 16:01 ET
Merus published news for 2021 q1
SEC form 10
2021-05-06 00:00 ET
Merus published news for 2021 q1
SEC form 6
2021-04-29 07:07 ET
Merus published news for 2021 q1
SEC form 6
2021-04-19 07:00 ET
Merus published news for 2021 q1
SEC form 6
2021-03-29 16:00 ET
Merus published news for 2020 q4
SEC form 10
2021-03-16 16:22 ET
Merus published news for 2020 q4
SEC form 6
2021-01-22 16:04 ET
Merus published news for 2020 q4
SEC form 6
2021-01-20 17:24 ET
Merus published news for 2020 q4
SEC form 6
2021-01-19 07:57 ET
Merus published news for 2020 q4
SEC form 10
2020-11-05 16:00 ET
Merus published news for 2020 q3